Theravance Biopharma
TBPH
#6133
Rank
$0.43 B
Marketcap
Cayman Islands
Country
$8.99
Share price
-1.43%
Change (1 day)
-18.35%
Change (1 year)
Categories
Theravance Biopharma (TBPH) - P/B ratio
P/B ratio as of April 2024 : 2.05
According to Theravance Biopharma
's latest financial reports the company has a price-to-book ratio of 2.05.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Theravance Biopharma - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.63 | 53.6% |
| 2022-12-31 | 1.71 | -171.13% |
| 2021-12-31 | -2.41 | -36.09% |
| 2020-12-31 | -3.76 | -42.93% |
| 2019-12-31 | -6.59 | -76.12% |
| 2018-12-31 | -27.6 | -310.82% |
| 2017-12-31 | 13.1 | 177.09% |
| 2016-12-31 | 4.73 | 84.61% |
| 2015-12-31 | 2.56 | 54.38% |
| 2014-12-31 | 1.66 | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Corcept Therapeutics
CORT | 4.79 | 133.66% | 🇺🇸 USA |
 Collegium Pharmaceutical
COLL | 6.14 | 199.74% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | 4.63 | 126.08% | 🇺🇸 USA |
 Catalent CTLT | 2.76 | 34.83% | 🇺🇸 USA |